Skin Biopsy for Phosphorylated α‐Synuclein in Mild Cognitive Impairment or Dementia Due to Lewy Body Disease in a Convenience Cohort from a Subspecialty Behavioral Neurology Practice
Movement Disorders · 2026
DOI: 10.1002/mds.70158 ↗Kurz gefasst
Fachartikel in der Zeitschrift Movement Disorders, 2026. Verfasst von Michael J Rigby und 24 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA. Hauptthemen laut MEDLINE: Lewy Body Disease, alpha-Synuclein, Cognitive Dysfunction, Skin. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Harry T. Mangurian Jr. Lewy Body Dementia program, NIDCD NIH HHS, NIA NIH HHS.
Themen: Demenz
Abstract (Originalsprache)
Background
Immunohistochemically detected phosphorylated α‐synuclein (p‐α‐syn) in cutaneous nerves has been found in >95% of patients meeting consensus criteria for dementia with Lewy bodies (DLB); however, its performance in prodromal stages (mild cognitive impairment‐Lewy body [MCI‐LB]) and clinical practice is unknown.
Objective
We evaluated skin biopsy for p‐α‐syn in a convenience cohort of patients with suspected MCI‐LB or DLB in a tertiary care setting.
Methods
53 patients underwent commercially available skin biopsy for skin nerve p‐α‐syn as part of a clinical evaluation for suspected MCI‐LB/DLB. Consensus MCI‐LB/DLB criteria blinded to skin biopsy result were applied through retrospective chart review; those not definitively meeting criteria were considered questionable synucleinopathy (QS).
Results
Median age at skin biopsy was 70 years (range, 43–87 years) with 81% men. 36 patients (68%) had positive skin biopsies. 32/43 (74%) patients meeting clinical consensus criteria for DLB/MCI‐LB had a positive skin biopsy, with higher frequency in MCI‐LB (87%) compared with DLB (60%). 4/10 (40%) QS had positive biopsies. One patient with a positive skin biopsy had no evidence of central nervous system (CNS) α‐syn on autopsy.
Conclusions
Positive skin biopsy for p‐α‐syn occurs across the spectrum of cognitive presentations of Lewy body disease including prodromal DLB, albeit at a lower frequency in this retrospective review of atypical cases compared with typical clinical presentations. A positive skin biopsy may not reflect CNS synucleinopathy as the etiology for a patient's symptoms in some cases. Longitudinal studies of skin biopsies for p‐α‐syn in suspected MCI‐LB/DLB with autopsy confirmation are needed. © 2025 International Parkinson and Movement Disorder Society.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.
- Department of Anatomic Pathology, Mayo Clinic, Rochester, Minnesota, USA.
- Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada.
- Department of Neurology, University of Kansas, Kansas City, Kansas, USA.
- Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota, USA.
- Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA.
ORCID-Profile: Rodolfo Savica, Toji Miyagawa, Erik K St Louis, Kejal Kantarci, Jonathan Graff-Radford, Stuart J McCarter
Förderung
- Harry T. Mangurian Jr. Lewy Body Dementia program
- NIDCD NIH HHS
- NIA NIH HHS
- NINDS NIH HHS
- National Institute of Neurological Disorders and Stroke
- National Institute on Aging
Zitieren
APA
Rigby, M. J., Botha, H., Barnard, L. R., Reichard, R. R., Larsen, R., Cogan, W., Switzer, A. R., Ramanan, V. K., Neth, B. J., Townley, R. A., Savica, R., Jones, D. T., Miyagawa, T., Fields, J. A., Vernon, C., Trottier, Z. A., Lowe, V. J., St Louis, E. K., Knopman, D. S., …, & McCarter, S. J. (2026). Skin Biopsy for Phosphorylated α‐Synuclein in Mild Cognitive Impairment or Dementia Due to Lewy Body Disease in a Convenience Cohort from a Subspecialty Behavioral Neurology Practice. Movement Disorders. https://doi.org/10.1002/mds.70158
Vancouver
Rigby MJ, Botha H, Barnard LR, Reichard RR, Larsen R, Cogan W, et al. Skin Biopsy for Phosphorylated α‐Synuclein in Mild Cognitive Impairment or Dementia Due to Lewy Body Disease in a Convenience Cohort from a Subspecialty Behavioral Neurology Practice. Movement Disorders. 2026. doi:10.1002/mds.70158
BibTeX
@article{Rigby2026,
author = {Rigby, Michael J and Botha, Hugo and Barnard, Leland R and Reichard, R Ross and Larsen, Rachel and Cogan, Wendy and Switzer, Aaron R and Ramanan, Vijay K and Neth, Bryan J and Townley, Ryan A and Savica, Rodolfo and Jones, David T and Miyagawa, Toji and Fields, Julie A and Vernon, Cynthia and Trottier, Zachary A and Lowe, Val J and St Louis, Erik K and Knopman, David S and Petersen, Ronald C and Dickson, Dennis W and Kantarci, Kejal and Graff-Radford, Jonathan and Boeve, Bradley F and McCarter, Stuart J},
title = {Skin Biopsy for Phosphorylated α‐Synuclein in Mild Cognitive Impairment or Dementia Due to Lewy Body Disease in a Convenience Cohort from a Subspecialty Behavioral Neurology Practice},
journal = {Movement Disorders},
year = {2026},
doi = {10.1002/mds.70158}
}
EUVIMED